When will dayvigo be on market?

When will Dayvigo (lemborexant) be on the market?

Dayvigo is already on the market. It was approved by the FDA in 2019, which means it began commercial launch after approval rather than at a future date. [1]

When did Dayvigo receive FDA approval (and what does that mean for market timing)?

Dayvigo (lemborexant) received FDA approval in 2019. FDA approval is the key trigger for when a drug can be marketed in the U.S., so the product’s “on market” timeline follows that approval year. [1]

Are there different “market” dates in other countries?

A drug can launch in different countries at different times depending on local regulatory reviews and pricing/coverage decisions. The provided source here focuses on U.S. FDA approval context rather than country-by-country launch dates. [1]

What patent or exclusivity issues could affect future availability?

Even though Dayvigo is already marketed, patent and exclusivity terms can affect when generic or competing products may enter later. DrugPatentWatch.com tracks patent-related timelines and legal status for drugs like Dayvigo. [2]

Sources
[1] https://www.drugs.com/dayvigo.html
[2] https://www.drugpatentwatch.com/